肾综合征出血热诊疗陕西省专家共识
摘要
<正>为规范肾综合征出血热的预防、诊断和治疗,根据本病临床特征和国内外重要文献,2016年开始编写,经过专家组反复讨论修改,于2018年3月发布《肾综合征出血热诊疗陕西省专家共识》(共识缩略词中英文对照见表1)。专家组由临床、基础和预防工作方面的专家组成,包括陕西省和部分其他省市的专家。肾综合征出血热是一种世界范围内广泛分布的自然疫源性疾病,危害严重,已成为一个全球关注的公共卫生问题[1-4]。中国是全世界受肾综合征出血热危害最为严重的国
引文
[1] Wu J, Wang DD, Li XL,et al. Increasing incidence of hemorrhagic fever with renal syndrome could be associated with livestock husbandry in changchun, northeastern china [J]. BMC Infectious Diseases, 2014,14:301.
[2] Jiang H, Du H, Wang LM,et al. Hemorrhagic fever with renal syndrome: Pathogenesis and clinical picture [J]. Frontiers in Cellular and Infection Microbiology, 2016,6:1.
[3] Jiang H, Zheng X, Wang L,et al. Hantavirus infection: A global zoonotic challenge [J]. Virologica Sinica, 2017,32(1):32-43.
[4] Schmaljohn C, Hjelle B. Hantaviruses: A global disease problem [J]. Emerging Infectious Diseases, 1997,3(2):95-104.
[5] 王芹,李建东,张全福,等. 2014年全国肾综合征出血热监测总结和病情分析 [J]. 疾病监测, 2016,31(3):192-199.
[6] Jonsson CB, Figueiredo LT, Vapalahti O. A global perspective on hantavirus ecology, epidemiology, and disease [J]. Clinical Microbiology Reviews, 2010,23(2):412-441.
[7] Hall PR, Leitao A, Ye C,et al. Small molecule inhibitors of hantavirus infection [J]. Bioorganic & Medicinal Chemistry Letters, 2010,20(23):7085-7091.
[8] Li G, Pan L, Mou D,et al. Characterization of truncated hantavirus nucleocapsid proteins and their application for serotyping [J]. Journal of Medical Virology, 2006,78(7):926-932.
[9] Song G. Epidemiological progresses of hemorrhagic fever with renal syndrome in china [J]. Chinese Medical Journal, 1999,112(5):472-477.
[10] Lee HW, Lee PW, Johnson KM. Isolation of the etiologic agent of korean hemorrhagic fever [J]. The Journal of Infectious Diseases, 1978,137(3):298-308.
[11] 王丽,魏菁,李慎,等. 中和试验发现西安地区为肾综合征出血热混合型疫区 [J]. 国际病毒学杂志, 2017,24(2):2-6.
[12] 华华,陈淑红,杨明,等. 2007-2016年黑龙江省肾综合征出血热疫情分析 [J]. 现代预防医学, 2017,44(22):4033-4035.
[13] 傅明慧,杨华富. 2004-2012年全国流行性出血热流行特征分析 [J]. 中国卫生产业, 2014,(28):35-36.
[14] 朱妮,刘峰,邱琳,等. 2011-2015年陕西省肾综合征出血热时空聚集性分析 [J]. 现代预防医学, 2017,44(9):1537-1552.
[15] Zhang S, Wang S, Yin W,et al. Epidemic characteristics of hemorrhagic fever with renal syndrome in china, 2006-2012 [J]. BMC Infectious Diseases, 2014,14(1):384.
[16] Huang LY, Zhou H, Yin WW,et al.The current epidemic situation and surveillance regarding hemorrhagic fever with renal syndrome in China[J]. Zhong Hua Liu Xing Bing Xue Za Zhi, 2012,33(7):685-691.
[17] 马超锋,余鹏博,李恒新,等. 中国肾综合征出血热流行现状及免疫策略 [J]. 中华预防医学杂志, 2014,48(12):1039-1041.
[18] 杨为松. 流行性出血热病毒抗原在感染胎儿脏器中分布的研究 [J]. 中华传染病杂志, 1988,6(1):128-129.
[19] 王敬军,魏菁,马长安,等. 肾综合征出血热自然感染和人工免疫后的抗体形成 [J]. 中华疾病控制杂志, 2014,18(5):387-390.
[20] 杭长寿,解燕乡,席玥,等. 关于肾综合征出血热疫苗的临床研究 [J]. 中华实验和临床病毒学杂志, 2006,20(4):423-425.
[21] 强美娟. 2010-2014年西安市长安区流行性出血热防治效果 [J]. 职业与健康, 2016,32(13):1806-1808.
[22] 陈桂兴,刘淑芳. 肾综合征出血热特异性抗体调查研究 [J]. 中国媒介生物学及控制杂志, 2002,13(3):210-211.
[23] 董关木,宋干. 汉坦病毒的致病性和免疫应答以及抗病毒和疫苗研究进展—第四届汉坦病毒国际会议部份内容介绍 [J]. 微生物学免疫学进展, 1999,(1):60-62.
[24] 邢玉芳,李德新,王世文. 肾综合征出血热疫苗研究进展及免疫效果评价 [J]. 中华实验和临床病毒学杂志, 2008,22(1):68-70.
[25] 徐校平,周卫群,阮玉华,等. 肾综合征出血热双价灭活疫苗免疫9年效果观察 [J]. 浙江预防医学, 2008,20(6):12-13.
[26] 王敬军,魏战臻,魏菁,等. 陕西省肾综合征出血热疫区人群国产疫苗免疫远期效果分析 [J]. 中华流行病学杂志, 2012,33(3):309-312.
[27] Yu PB, Tian HY, Ma CF,et al. Hantavirus infection in rodents and haemorrhagic fever with renal syndrome in shaanxi province, china, 1984-2012 [J]. Epidemiology and Infection, 2015,143(2):405-411.
[28] Gavrilovskaya IN, Gorbunova EE, Mackow NA,et al. Hantaviruses direct endothelial cell permeability by sensitizing cells to the vascular permeability factor vegf, while angiopoietin 1 and sphingosine 1-phosphate inhibit hantavirus-directed permeability [J]. Journal of Virology, 2008,82(12):5797-5806.
[29] Gorbunova EE, Gavrilovskaya IN, Pepini T,et al. Vegfr2 and src kinase inhibitors suppress andes virus-induced endothelial cell permeability [J]. Journal of Virology, 2011,85(5):2296-2303.
[30] Hayasaka D, Maeda K, Ennis FA,et al. Increased permeability of human endothelial cell line ea.Hy926 induced by hantavirus-specific cytotoxict lymphocytes [J]. Virus Research, 2007,123(2):120-127.
[31] Yi J, Xu Z, Zhuang R,et al. Hantaan virus rna load in patients having hemorrhagic fever with renal syndrome: Correlation with disease severity [J]. The Journal of Infectious Diseases, 2013,207(9):1457-1461.
[32] 罗端德,曾令兰,蔡淑清,等. 流行性出血热病毒对正常人骨髓细胞致病变作用 [J]. 中华传染病杂志, 1994,12(3):131-132.
[33] Jiang H, Wang PZ, Zhang Y,et al. Hantaan virus induces toll-like receptor 4 expression, leading to enhanced production of beta interferon, interleukin-6 and tumor necrosis factor-alpha [J]. Virology, 2008,380(1):52-59.
[34] Wang PZ, Li ZD, Yu HT,et al. Elevated serum concentrations of inflammatory cytokines and chemokines in patients with haemorrhagic fever with renal syndrome [J]. The Journal of International Medical Research, 2012,40(2):648-656.
[35] Bossi F, Fischetti F, Pellis V,et al. Platelet-activating factor and kinin-dependent vascular leakage as a novel functional activity of the soluble terminal complement complex [J]. Journal of Immunology, 2004,173(11):6921-6927.
[36] Bjorkstrom NK, Lindgren T, Stoltz M,et al. Rapid expansion and long-term persistence of elevated nk cell numbers in humans infected with hantavirus [J]. The Journal of Experimental Medicine, 2011,208(1):13-21.
[37] 于雷,牛俊奇. 肾综合征出血热并发肝脏损害临床分析 [J]. 山东医药, 2007,47(31):79-80.
[38] 刘继锋,相晓妹,马超锋,等. 2011-2013年西安市肾综合征出血热流行特征分析 [J]. 现代预防医学, 2015,42(9):1553-1554.
[39] 吕耀青,王烨,杜虹,等. 儿童肾综合征出血热31例临床分析 [J]. 临床医学, 2017,(4):95-97.
[40] 邓丽宁,侯宏波. 小儿肾综合征出血热35例临床分析 [J]. 武警后勤学院学报:医学版, 2014,123(7):602-603.
[41] 辛颖军,李光超. 儿童流行性出血热120例临床分析 [J]. 吉林医学, 2010,31(25):4356.
[42] 白雪帆,徐志凯. 肾综合征出血热[M].北京: 人民卫生出版社,2013:192-193.
[43] 刘泽富,白雪帆,何文革,等. 肾综合征出血热2263例 [J]. 中华传染病杂志, 2003,21(5):365-368.
[44] 沙琪,程慧桢,崔凤芹. 妊娠肾综合征出血热21例临床分析 [J]. 山东医药, 2000,40(12):3.
[45] 李红兵,程云,李永涛,等. 227例肾综合征出血热住院病例临床分析 [J]. 中华传染病杂志, 2013,31(1):49-50.
[46] 张国斌. Elisa检测流行性出血热抗体价值的分析 [J]. 中国实用医药, 2016,11(26):54-55.
[47] 郑曲波, 罗端德, 曾令兰. 逆转录-聚合酶链反应用于肾综合征出血热病毒基因分型诊断 [J]. 中华传染病杂志, 1999,17(3):197-198.
[48] 张静. 流行性出血热肾脏超声表现特征 [J]. 实用医学杂志, 2008,24(9):1557.
[49] 陈兵. 彩色多普勒超声检测流行性出血热90例肾内血流变化意义分析 [J]. 中国现代医生, 2015,53(27):109-111.
[50] 刘世玲. 流行性出血热心电图检查与心电图表现分析 [J]. 中西医结合心血管病杂志, 2016,4(28):32.
[51] 李三景,任娜,陈媛媛,等. 流行性出血热56例临床分析 [J]. 中国医药导报, 2011,16:190-192.
[52] Du H, Li J, Jiang W,et al. Clinical study of critical patients with hemorrhagic fever with renal syndrome complicated by acute respiratory distress syndrome [J]. PloS One, 2014,9(2):e89740.
[53] Du H, Wang PZ, Li J,et al. Clinical characteristics and outcomes in critical patients with hemorrhagic fever with renal syndrome [J]. BMC Infectious Diseases, 2014,14:191.
[54] Du H, Li J, Yu HT,et al. Early indicators of severity and construction of a risk model for prognosis based upon laboratory parameters in patients with hemorrhagic fever with renal syndrome [J]. Clinical Chemistry and Laboratory Medicine, 2014,52(11):1667-1675.
[55] Wang M, Wang J, Wang T,et al. Thrombocytopenia as a predictor of severe acute kidney injury in patients with hantaan virus infections [J]. PloS One, 2013,8(1):e53236.
[56] 熊莉娟,罗端德,李淑莉,等. 肾综合征出血热急性期外周血细胞因子的检测及其临床意义 [J]. 临床内科杂志, 2002,19(5):345-346.
[57] 姚上明,胡敏涛,张波,等. 异甘草酸镁治疗肾综合征出血热疗效观察 [J]. 中国微循环, 2007,11(4):341.
[58] Huggins JW, Hsiang CM, Cosgriff TM,et al. Prospective, double-blind, concurrent, placebo-controlled clinical trial of intravenous ribavirin therapy of hemorrhagic fever with renal syndrome [J]. The Journal of Infectious Diseases, 1991,164(6):1119-1127.
[59] Moreli ML, Marques-Silva AC, Pimentel VA,et al. Effectiveness of the ribavirin in treatment of hantavirus infections in the americas and eurasia: A meta-analysis [J]. Virusdisease, 2014,25(3):385-389.
[60] 中华医学会重症医学分会. 中国严重脓毒症/脓毒性休克治疗指南 [J]. 中华危重症急救医学, 2015,27(6):401-426.
[61] Bansal M, Farrugia A, Balboni S,et al. Relative survival benefit and morbidity with fluids in severe sepsis - a network meta-analysis of alternative therapies [J]. Current drug safety, 2013,8(4):236-245.
[62] Investigators SS, Finfer S, Bellomo R,et al. Effect of baseline serum albumin concentration on outcome of resuscitation with albumin or saline in patients in intensive care units: Analysis of data from the saline versus albumin fluid evaluation (safe) study [J]. BMJ, 2006,333(7577):1044.
[63] Brunkhorst FM, Engel C, Bloos F,et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis [J]. The New England Journal of Medicine, 2008,358(2):125-139.
[64] Guidet B, Martinet O, Boulain T,et al. Assessment of hemodynamic efficacy and safety of 6% hydroxyethylstarch 130/0.4 vs. 0.9% nacl fluid replacement in patients with severe sepsis: The crystmas study [J]. Critical Care, 2012,16(3):R94.
[65] McIntyre LA, Fergusson D, Cook DJ,et al. Fluid resuscitation in the management of early septic shock (finess): A randomized controlled feasibility trial [J]. Canadian Journal of Anaesthesia, 2008,55(12):819-826.
[66] Perner A, Haase N, Guttormsen AB,et al. Hydroxyethyl starch 130/0.42 versus ringer's acetate in severe sepsis [J]. The New England Journal of Medicine, 2012,367(2):124-134.
[67] Veneman TF, Oude Nijhuis J, Woittiez AJ. Human albumin and starch administration in critically ill patients: A prospective randomized clinical trial [J]. Wiener klinische Wochenschrift, 2004,116(9-10):305-309.
[68] Agrawal A, Gupta A, Consul S,et al. Comparative study of dopamine and norepinephrine in the management of septic shock [J]. Saudi Journal of Anaesthesia, 2011,5(2):162-166.
[69] De Backer D, Biston P, Devriendt J,et al. Comparison of dopamine and norepinephrine in the treatment of shock [J]. The New England Journal of Medicine, 2010,362(9):779-789.
[70] Bartel B. Norepinephrine VS. Dopamine: New recommendations for initial vasopressor selection in septic shock [J]. South Dakota medicine : the journal of the South Dakota State Medical Association, 2014,67(5):200-201.
[71] 《中国国家处方集》编委会. 中国国家处方集化学药品与生物制品卷, 2010:254.
[72] Du Y, Zhang H, Feng X. Continuous renal replacement therapy and mild hypothermia for acute left heart failure after cardiovascular surgery [J]. The Journal of Thoracic and Cardiovascular Surgery, 2014,148(1):e137-139.
[73] 杜虹,李璟,于海涛,等. 连续性肾脏替代治疗与间断性血液透析在重症肾综合征出血热治疗中的应用 [J]. 传染病信息, 2014,27(1):18-21.
[74] 杜虹,李璟,王平忠,等. 危重型肾综合征出血热患者肾脏替代治疗的应用 [J]. 解放军医药杂志, 2014,26(4):45-48.
[75] 卢炜,李聘进,郭利萍. 肾综合征出血热致肾破裂出血的ct表现 [J]. 中国中西医结合影像学杂志, 2016,14(5):579-580.
[76] 李冰,谢玉梅,白雪帆,等. 肾综合征出血热并发自发性肾破裂11例临床回顾性分析 [J]. 第四军医大学学报, 2009,30(18):1775-1777.
[77] 李倩,杨家丽. 不同血管通路在肾综合出血热患者透析中的应用[J]. 陕西医学杂志, 2017,46(2):268-269.
[2] Jiang H, Du H, Wang LM,et al. Hemorrhagic fever with renal syndrome: Pathogenesis and clinical picture [J]. Frontiers in Cellular and Infection Microbiology, 2016,6:1.
[3] Jiang H, Zheng X, Wang L,et al. Hantavirus infection: A global zoonotic challenge [J]. Virologica Sinica, 2017,32(1):32-43.
[4] Schmaljohn C, Hjelle B. Hantaviruses: A global disease problem [J]. Emerging Infectious Diseases, 1997,3(2):95-104.
[5] 王芹,李建东,张全福,等. 2014年全国肾综合征出血热监测总结和病情分析 [J]. 疾病监测, 2016,31(3):192-199.
[6] Jonsson CB, Figueiredo LT, Vapalahti O. A global perspective on hantavirus ecology, epidemiology, and disease [J]. Clinical Microbiology Reviews, 2010,23(2):412-441.
[7] Hall PR, Leitao A, Ye C,et al. Small molecule inhibitors of hantavirus infection [J]. Bioorganic & Medicinal Chemistry Letters, 2010,20(23):7085-7091.
[8] Li G, Pan L, Mou D,et al. Characterization of truncated hantavirus nucleocapsid proteins and their application for serotyping [J]. Journal of Medical Virology, 2006,78(7):926-932.
[9] Song G. Epidemiological progresses of hemorrhagic fever with renal syndrome in china [J]. Chinese Medical Journal, 1999,112(5):472-477.
[10] Lee HW, Lee PW, Johnson KM. Isolation of the etiologic agent of korean hemorrhagic fever [J]. The Journal of Infectious Diseases, 1978,137(3):298-308.
[11] 王丽,魏菁,李慎,等. 中和试验发现西安地区为肾综合征出血热混合型疫区 [J]. 国际病毒学杂志, 2017,24(2):2-6.
[12] 华华,陈淑红,杨明,等. 2007-2016年黑龙江省肾综合征出血热疫情分析 [J]. 现代预防医学, 2017,44(22):4033-4035.
[13] 傅明慧,杨华富. 2004-2012年全国流行性出血热流行特征分析 [J]. 中国卫生产业, 2014,(28):35-36.
[14] 朱妮,刘峰,邱琳,等. 2011-2015年陕西省肾综合征出血热时空聚集性分析 [J]. 现代预防医学, 2017,44(9):1537-1552.
[15] Zhang S, Wang S, Yin W,et al. Epidemic characteristics of hemorrhagic fever with renal syndrome in china, 2006-2012 [J]. BMC Infectious Diseases, 2014,14(1):384.
[16] Huang LY, Zhou H, Yin WW,et al.The current epidemic situation and surveillance regarding hemorrhagic fever with renal syndrome in China[J]. Zhong Hua Liu Xing Bing Xue Za Zhi, 2012,33(7):685-691.
[17] 马超锋,余鹏博,李恒新,等. 中国肾综合征出血热流行现状及免疫策略 [J]. 中华预防医学杂志, 2014,48(12):1039-1041.
[18] 杨为松. 流行性出血热病毒抗原在感染胎儿脏器中分布的研究 [J]. 中华传染病杂志, 1988,6(1):128-129.
[19] 王敬军,魏菁,马长安,等. 肾综合征出血热自然感染和人工免疫后的抗体形成 [J]. 中华疾病控制杂志, 2014,18(5):387-390.
[20] 杭长寿,解燕乡,席玥,等. 关于肾综合征出血热疫苗的临床研究 [J]. 中华实验和临床病毒学杂志, 2006,20(4):423-425.
[21] 强美娟. 2010-2014年西安市长安区流行性出血热防治效果 [J]. 职业与健康, 2016,32(13):1806-1808.
[22] 陈桂兴,刘淑芳. 肾综合征出血热特异性抗体调查研究 [J]. 中国媒介生物学及控制杂志, 2002,13(3):210-211.
[23] 董关木,宋干. 汉坦病毒的致病性和免疫应答以及抗病毒和疫苗研究进展—第四届汉坦病毒国际会议部份内容介绍 [J]. 微生物学免疫学进展, 1999,(1):60-62.
[24] 邢玉芳,李德新,王世文. 肾综合征出血热疫苗研究进展及免疫效果评价 [J]. 中华实验和临床病毒学杂志, 2008,22(1):68-70.
[25] 徐校平,周卫群,阮玉华,等. 肾综合征出血热双价灭活疫苗免疫9年效果观察 [J]. 浙江预防医学, 2008,20(6):12-13.
[26] 王敬军,魏战臻,魏菁,等. 陕西省肾综合征出血热疫区人群国产疫苗免疫远期效果分析 [J]. 中华流行病学杂志, 2012,33(3):309-312.
[27] Yu PB, Tian HY, Ma CF,et al. Hantavirus infection in rodents and haemorrhagic fever with renal syndrome in shaanxi province, china, 1984-2012 [J]. Epidemiology and Infection, 2015,143(2):405-411.
[28] Gavrilovskaya IN, Gorbunova EE, Mackow NA,et al. Hantaviruses direct endothelial cell permeability by sensitizing cells to the vascular permeability factor vegf, while angiopoietin 1 and sphingosine 1-phosphate inhibit hantavirus-directed permeability [J]. Journal of Virology, 2008,82(12):5797-5806.
[29] Gorbunova EE, Gavrilovskaya IN, Pepini T,et al. Vegfr2 and src kinase inhibitors suppress andes virus-induced endothelial cell permeability [J]. Journal of Virology, 2011,85(5):2296-2303.
[30] Hayasaka D, Maeda K, Ennis FA,et al. Increased permeability of human endothelial cell line ea.Hy926 induced by hantavirus-specific cytotoxict lymphocytes [J]. Virus Research, 2007,123(2):120-127.
[31] Yi J, Xu Z, Zhuang R,et al. Hantaan virus rna load in patients having hemorrhagic fever with renal syndrome: Correlation with disease severity [J]. The Journal of Infectious Diseases, 2013,207(9):1457-1461.
[32] 罗端德,曾令兰,蔡淑清,等. 流行性出血热病毒对正常人骨髓细胞致病变作用 [J]. 中华传染病杂志, 1994,12(3):131-132.
[33] Jiang H, Wang PZ, Zhang Y,et al. Hantaan virus induces toll-like receptor 4 expression, leading to enhanced production of beta interferon, interleukin-6 and tumor necrosis factor-alpha [J]. Virology, 2008,380(1):52-59.
[34] Wang PZ, Li ZD, Yu HT,et al. Elevated serum concentrations of inflammatory cytokines and chemokines in patients with haemorrhagic fever with renal syndrome [J]. The Journal of International Medical Research, 2012,40(2):648-656.
[35] Bossi F, Fischetti F, Pellis V,et al. Platelet-activating factor and kinin-dependent vascular leakage as a novel functional activity of the soluble terminal complement complex [J]. Journal of Immunology, 2004,173(11):6921-6927.
[36] Bjorkstrom NK, Lindgren T, Stoltz M,et al. Rapid expansion and long-term persistence of elevated nk cell numbers in humans infected with hantavirus [J]. The Journal of Experimental Medicine, 2011,208(1):13-21.
[37] 于雷,牛俊奇. 肾综合征出血热并发肝脏损害临床分析 [J]. 山东医药, 2007,47(31):79-80.
[38] 刘继锋,相晓妹,马超锋,等. 2011-2013年西安市肾综合征出血热流行特征分析 [J]. 现代预防医学, 2015,42(9):1553-1554.
[39] 吕耀青,王烨,杜虹,等. 儿童肾综合征出血热31例临床分析 [J]. 临床医学, 2017,(4):95-97.
[40] 邓丽宁,侯宏波. 小儿肾综合征出血热35例临床分析 [J]. 武警后勤学院学报:医学版, 2014,123(7):602-603.
[41] 辛颖军,李光超. 儿童流行性出血热120例临床分析 [J]. 吉林医学, 2010,31(25):4356.
[42] 白雪帆,徐志凯. 肾综合征出血热[M].北京: 人民卫生出版社,2013:192-193.
[43] 刘泽富,白雪帆,何文革,等. 肾综合征出血热2263例 [J]. 中华传染病杂志, 2003,21(5):365-368.
[44] 沙琪,程慧桢,崔凤芹. 妊娠肾综合征出血热21例临床分析 [J]. 山东医药, 2000,40(12):3.
[45] 李红兵,程云,李永涛,等. 227例肾综合征出血热住院病例临床分析 [J]. 中华传染病杂志, 2013,31(1):49-50.
[46] 张国斌. Elisa检测流行性出血热抗体价值的分析 [J]. 中国实用医药, 2016,11(26):54-55.
[47] 郑曲波, 罗端德, 曾令兰. 逆转录-聚合酶链反应用于肾综合征出血热病毒基因分型诊断 [J]. 中华传染病杂志, 1999,17(3):197-198.
[48] 张静. 流行性出血热肾脏超声表现特征 [J]. 实用医学杂志, 2008,24(9):1557.
[49] 陈兵. 彩色多普勒超声检测流行性出血热90例肾内血流变化意义分析 [J]. 中国现代医生, 2015,53(27):109-111.
[50] 刘世玲. 流行性出血热心电图检查与心电图表现分析 [J]. 中西医结合心血管病杂志, 2016,4(28):32.
[51] 李三景,任娜,陈媛媛,等. 流行性出血热56例临床分析 [J]. 中国医药导报, 2011,16:190-192.
[52] Du H, Li J, Jiang W,et al. Clinical study of critical patients with hemorrhagic fever with renal syndrome complicated by acute respiratory distress syndrome [J]. PloS One, 2014,9(2):e89740.
[53] Du H, Wang PZ, Li J,et al. Clinical characteristics and outcomes in critical patients with hemorrhagic fever with renal syndrome [J]. BMC Infectious Diseases, 2014,14:191.
[54] Du H, Li J, Yu HT,et al. Early indicators of severity and construction of a risk model for prognosis based upon laboratory parameters in patients with hemorrhagic fever with renal syndrome [J]. Clinical Chemistry and Laboratory Medicine, 2014,52(11):1667-1675.
[55] Wang M, Wang J, Wang T,et al. Thrombocytopenia as a predictor of severe acute kidney injury in patients with hantaan virus infections [J]. PloS One, 2013,8(1):e53236.
[56] 熊莉娟,罗端德,李淑莉,等. 肾综合征出血热急性期外周血细胞因子的检测及其临床意义 [J]. 临床内科杂志, 2002,19(5):345-346.
[57] 姚上明,胡敏涛,张波,等. 异甘草酸镁治疗肾综合征出血热疗效观察 [J]. 中国微循环, 2007,11(4):341.
[58] Huggins JW, Hsiang CM, Cosgriff TM,et al. Prospective, double-blind, concurrent, placebo-controlled clinical trial of intravenous ribavirin therapy of hemorrhagic fever with renal syndrome [J]. The Journal of Infectious Diseases, 1991,164(6):1119-1127.
[59] Moreli ML, Marques-Silva AC, Pimentel VA,et al. Effectiveness of the ribavirin in treatment of hantavirus infections in the americas and eurasia: A meta-analysis [J]. Virusdisease, 2014,25(3):385-389.
[60] 中华医学会重症医学分会. 中国严重脓毒症/脓毒性休克治疗指南 [J]. 中华危重症急救医学, 2015,27(6):401-426.
[61] Bansal M, Farrugia A, Balboni S,et al. Relative survival benefit and morbidity with fluids in severe sepsis - a network meta-analysis of alternative therapies [J]. Current drug safety, 2013,8(4):236-245.
[62] Investigators SS, Finfer S, Bellomo R,et al. Effect of baseline serum albumin concentration on outcome of resuscitation with albumin or saline in patients in intensive care units: Analysis of data from the saline versus albumin fluid evaluation (safe) study [J]. BMJ, 2006,333(7577):1044.
[63] Brunkhorst FM, Engel C, Bloos F,et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis [J]. The New England Journal of Medicine, 2008,358(2):125-139.
[64] Guidet B, Martinet O, Boulain T,et al. Assessment of hemodynamic efficacy and safety of 6% hydroxyethylstarch 130/0.4 vs. 0.9% nacl fluid replacement in patients with severe sepsis: The crystmas study [J]. Critical Care, 2012,16(3):R94.
[65] McIntyre LA, Fergusson D, Cook DJ,et al. Fluid resuscitation in the management of early septic shock (finess): A randomized controlled feasibility trial [J]. Canadian Journal of Anaesthesia, 2008,55(12):819-826.
[66] Perner A, Haase N, Guttormsen AB,et al. Hydroxyethyl starch 130/0.42 versus ringer's acetate in severe sepsis [J]. The New England Journal of Medicine, 2012,367(2):124-134.
[67] Veneman TF, Oude Nijhuis J, Woittiez AJ. Human albumin and starch administration in critically ill patients: A prospective randomized clinical trial [J]. Wiener klinische Wochenschrift, 2004,116(9-10):305-309.
[68] Agrawal A, Gupta A, Consul S,et al. Comparative study of dopamine and norepinephrine in the management of septic shock [J]. Saudi Journal of Anaesthesia, 2011,5(2):162-166.
[69] De Backer D, Biston P, Devriendt J,et al. Comparison of dopamine and norepinephrine in the treatment of shock [J]. The New England Journal of Medicine, 2010,362(9):779-789.
[70] Bartel B. Norepinephrine VS. Dopamine: New recommendations for initial vasopressor selection in septic shock [J]. South Dakota medicine : the journal of the South Dakota State Medical Association, 2014,67(5):200-201.
[71] 《中国国家处方集》编委会. 中国国家处方集化学药品与生物制品卷, 2010:254.
[72] Du Y, Zhang H, Feng X. Continuous renal replacement therapy and mild hypothermia for acute left heart failure after cardiovascular surgery [J]. The Journal of Thoracic and Cardiovascular Surgery, 2014,148(1):e137-139.
[73] 杜虹,李璟,于海涛,等. 连续性肾脏替代治疗与间断性血液透析在重症肾综合征出血热治疗中的应用 [J]. 传染病信息, 2014,27(1):18-21.
[74] 杜虹,李璟,王平忠,等. 危重型肾综合征出血热患者肾脏替代治疗的应用 [J]. 解放军医药杂志, 2014,26(4):45-48.
[75] 卢炜,李聘进,郭利萍. 肾综合征出血热致肾破裂出血的ct表现 [J]. 中国中西医结合影像学杂志, 2016,14(5):579-580.
[76] 李冰,谢玉梅,白雪帆,等. 肾综合征出血热并发自发性肾破裂11例临床回顾性分析 [J]. 第四军医大学学报, 2009,30(18):1775-1777.
[77] 李倩,杨家丽. 不同血管通路在肾综合出血热患者透析中的应用[J]. 陕西医学杂志, 2017,46(2):268-269.